Company record
SUN PHARMA /TARO
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about SUN PHARMA /TARO.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Sep 23 | Class II | SUN PHARMA /TARO Drug |
Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5 Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH). |
| Dec 24, 2025 | Class II | SUN PHARMA /TARO Drug |
Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Canada; Dist. by: Taro Pharmaceuticals USA, Inc., NY 10532. NDC 51672-1351-08 Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint |